Identification of new polymorphisms in the CACNA1S gene

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 1, 2003, Pages 20-22

  Carsana, Antonella ^a   Fortunato, Giuliana ^a   De Sarno, Claudia ^a   Brancadoro, Virginia ^a   Salvatore, Francesco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

CACAN1S; Calcium channel; Hypokalemic periodic paralysis; Malignant hyperthermia; Single nucleotide polymorphism (SNP)

Indexed keywords

1,4 DIHYDROPYRIDINE RECEPTOR; ALANINE; ASPARAGINE; NUCLEOTIDE; RESTRICTION ENDONUCLEASE;

ALPHA CHAIN; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; EXON; GENE IDENTIFICATION; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; GENETIC DISORDER; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOSITY; HUMAN; HYPOKALEMIA; INTRON; ITALY; MALIGNANT HYPERTHERMIA; METHODOLOGY; NUCLEOTIDE SEQUENCE; PERIODIC PARALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM;

AMINO ACID SUBSTITUTION; CALCIUM CHANNELS, L-TYPE; DNA PRIMERS; EXONS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; INTRONS; MALIGNANT HYPERTHERMIA; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; RESTRICTION MAPPING;

INSERTION SEQUENCES;

EID: 0037216203     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.004     Document Type: Article

References (8)

1. Monnier N, Procaccio V, Stieglitz P, Lunardi J. Malignant hyperthermia susceptibility is associated with a mutation of the α1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium channel receptor in skeletal muscle. Am J Hum Genet 1997; 60:1316-1.
2. Jurkat-Rott K, McCharty T, Lehmann-Horn F. Genetic and pathogenesis of malignant hyperthermia. Muscle Nerve 2000; 23:4-17.
3. Jurkat-Rott K, Lehmann-Horn F, Elbaz A, Heine R, Gregg RG, Hogan K, et al. A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet 1994; 3:1415-9.
4. Elbaz A, Vale-Santos J, Jurkat-Rott K, Lapie P, Ophoff RA, Bady B, et al. Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 Caucasian families. Am J Hum Genet 1995; 56:374-80
5. Jurkatt-Rott K, Mitrovic N, Hang C, Kouzmekine A, Iaizzo P, Herzog J, et al. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci USA. 2000; 97:9832-3.
6. Carsana A, Fortunato G, Tinto N, Brancadoro V, Salvatore F. Genetic linkage analysis in Italian malignant hyperthermia families [abstract]. Annual Meeting of the European Malignant Hyperthermia Group 1998, Napoli, 21-23 May.
7. den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations. Hum Genet 2001; 109:121-4.
8. European Malignant Hyperthermia Group. Malignant hyperpyrexia: a protocol for the investigation of malignant hyperthermia. Br J Anaesth 1984; 56:1267-9.